Synapse - Mark Robson

Incidence of brain metastases in patients receiving neoadjuvant chemotherapy (NAC) with trastuzumab and pertuzumab (HP) in HER2-positive early breast cancer (BC)

Meeting Abstract

Ferraro, E.; Barrio, A. V.; Patil, S.; Robson, M. E.; Dang, C. T.
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Genomic methods identify homologous recombination deficiency in pancreas adenocarcinoma and optimize treatment selection

Journal Article

Park, W.; Chen, J.; Chou, J. F.; Varghese, A. M.; Yu, K. H.; Wong, W.; Capanu, M.; Balachandran, V.; McIntyre, C. A.; El Dika, I.; more...
Clinical Cancer Research (2020)

Fulltext@MSK | Save

Genomic landscape of breast cancer occurring in elderly individuals

Meeting Abstract

Selenica, P.; Pareja, F.; Tadros, A.; Ferrando, L.; Brown, D. N.; Zhang, H.; Razavi, P.; Mandelker, D.; Robson, M. E.; Chandarlapaty, S.; more...
Cancer Research (2020)

Fulltext@MSK | Save

Surgical decision making and clinical outcomes in breast cancer (BC) patients (pts) with germline alterations in moderate risk BC susceptibility genes (CHEK2, PALB2 and ATM)

Meeting Abstract

dos Anjos, C. H.; Amoros, K.; Pilewskie, M.; Braunstein, L.; Robson, M.
Cancer Research (2020)

Fulltext@MSK | Save

Impact of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 guideline updates on HER2 assessment in breast cancer with equivocal HER2 immunohistochemistry results with focus on cases with HER2/CEP17 ratio <2.0 and average HER2 copy number ≥4.0 and <6.0